Sensing cannabis and opioids in exhaled breath by infrared spectroscopy
Techniques for detecting narcotics such as tetrahydrocannabinol (THC) or other aerosols such as cannabinoids, opioids, etc., in an exhaled breath using infrared spectroscopy are provided. An example of an apparatus for sensing THC according to the disclosure includes a tunable laser source, at least one photodetector, a sample cell disposed between the tunable laser source and the at least one photodetector, and at least one processor operably coupled to the tunable laser source and the at least one photodetector and configured to provide a control signal to the tunable laser source, determine a spectral absorption line or group of absorption lines associated with THC based on an intensity of infrared light detected by the at least one photodetector, and determine a THC concentration value based on the spectral absorption line intensity. A laser-based apparatus for sensing narcotics in exhaled breath may include a single, dual, or multi-optical frequency comb spectrometer.
1. A method of sensing a narcotic in exhaled breath, comprising:
receiving a breath input from a test subject with a filter material;
disposing the filter material including the breath input in an optical path between a laser source and a photodetector, wherein the laser source is an optical frequency comb laser with a separation of laser modes of 0.33 cm −1 or less;
detecting an intensity of infrared light that traverses the filter material including the breath input with the photodetector;
determining one or more spectral absorption lines associated with the narcotic based on the intensity of the infrared light as a function of photon energy;
determining a narcotic concentration value based on the one or more spectral absorption lines; and
outputting the narcotic concentration value.
2. The method of claim 1 wherein receiving the breath input from the test subject includes providing the test subject a breath sampler device comprising a tube and the filter material.
3. The method of claim 1 wherein the narcotic is tetrahydrocannabinol (THC) and the one or more spectral absorption lines associated with THC includes a spectral absorption line at approximately 1036.94 cm −1 .
4. The method of claim 1 wherein the narcotic is oxycodone and the one or more spectral absorption lines associated with oxycodone are approximately between 700-1500 cm −1 .
5. The method of claim 1 wherein the narcotic is fentanyl and the one or more spectral absorption lines associated with fentanyl are approximately between 600-1500 cm −1 .
6. The method of claim 1 wherein the narcotic is morphine and the one or more spectral absorption lines associated with morphine are approximately between 600-1130 cm −1 .
7. The method of claim 1 wherein the narcotic is tetrahydrocannabinol (THC) and the one or more spectral absorption lines associated with THC are approximately between 600-1700 cm −1 .
8. The method of claim 1 wherein the one or more spectral absorption lines includes one or more spectral absorption lines known to be associated with Cannabidiol (CBD).
9. An apparatus for sensing a narcotic in an exhaled breath, comprising:
an optical frequency comb laser with a separation of laser modes of 0.33 cm −1 or less;
at least one photodetector;
a sample cell disposed between the optical frequency comb laser and the at least one photodetector, wherein the sample cell includes an aerosol obtained from the exhaled breath; and
at least one processor operably coupled to the optical frequency comb laser and the at least one photodetector and configured to:
provide a control signal to the optical frequency comb laser;
determine one or more spectral absorption lines associated with the narcotic based on an intensity of infrared light detected by the at least one photodetector; and
determine a narcotic concentration value based on the spectral absorption lines.
10. The apparatus of claim 9 further comprising a breath sampler device including a tube operably coupled to the filter material that is configured to receive a breath input from a test subject.
11. The apparatus of claim 9 wherein the at least one processor is configured to determine the one or more spectral absorption lines is associated with THC as approximately 1036.94 cm −1 .
12. The apparatus of claim 9 wherein the at least one processor is configured to determine the one or more spectral absorption lines known to be associated with THC.
13. The apparatus of claim 9 wherein the narcotic is oxycodone and the at least one processor is configured to determine the one or more spectral absorption lines associated with oxycodone are approximately between 700-1500 cm −1 .
14. The apparatus of claim 9 wherein the narcotic is fentanyl and the at least one processor is configured to determine the one or more spectral absorption lines associated with fentanyl are approximately between 600-1500 cm −1 .
15. The apparatus of claim 9 wherein the narcotic is morphine and the at least one processor is configured to determine the one or more spectral absorption lines associated with morphine are approximately between 600-1130 cm −1 .
16. An apparatus for sensing a narcotic in an exhaled breath, comprising:
an optical frequency comb laser;
at least one photodetector;
a filter material disposed between the optical frequency comb laser and the at least one photodetector, wherein the filter material includes an aerosol obtained from the exhaled breath;
at least one processor operably coupled to the optical frequency comb laser and the at least one photodetector and configured to:
pulse the optical frequency comb laser at a mode lock pulse frequency of approximately 10 Gigahertz or less and a separation between laser modes of 0.33 cm −1 in a mode locked condition;
determine one or more spectral absorption lines associated with the narcotic based on an intensity of infrared light detected by the at least one photodetector; and
determine a narcotic concentration value based on the spectral absorption lines.